CONTINUING MEDICAL EDUCATION AND CONTINUING CERTIFICATION
The 112th USCAP Annual Meeting and associated events will offer Continuing Medical Education (CME) credits. The deadline to claim CME is September 30, 2023.
CONTINUING MEDICAL EDUCATION
The United States and Canadian Academy of Pathology (USCAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity will offer Lifelong Learning credit in the American Board of Pathology’s (ABPath) Continuing Certification program.
ROYAL COLLEGE OF PHYSICIANS AND SURGEONS OF CANADA
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
CREDIT DESIGNATION BY REGISTRATION TYPE
Full Access Registration
The United States and Canadian Academy of Pathology designates this Other activity (live and enduring materials) for a maximum of 203.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
The United States and Canadian Academy of Pathology designates this enduring activity for a maximum of 166.75 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Companion Society Meetings
CME credits for these meetings are variable. Detailed credit information is available on each meeting page.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. USCAP has reviewed the disclosures and mitigated all relevant financial relationships. All faculty disclosures are available on the individual session pages.
The following Education Committee members reported financial relationships:
Jennifer Gordetsky: Consultant: Janssen
Tamara Lotan: Grant or Research Support: Myriad
Liron Pantanowitz: Consultant: Hamamatsu, Praxis Medical; Advisory Board Member: Ibex
David Schaeffer: Consultant: Alimentiv, Astaellas, AstraZeneca, NEED Inc;
Stock Ownership: Satisfai Health Inc.
Lynette Sholl: Grant or Research Support: Bristol Myers Squibb; Consultant: GV20 Therapeutics, Genentech, Lilly; Advisory Board Member: AstraZeneca
Charles “Matt” Quick: Consultant: Myriad Genetics
The following Education Committee members reported no relevant financial relationships: Adebowale Adeniran, Kimberly Allison, Justin Bishop, Laura Collins, Carla Ellis, Yuri Fedoriw, Karen Fritchie, Sarah Gibson, Kristin Jensen, Levon Katsakhyan, Melinda Lerwill, M. Beatriz Lopes, Terri Mason, Julia Naso, Nicole Panarelli, Carlos Parra-Herran, Rajiv Patel, Olga Weinberg, Ilan Weinreb, Maria Westerhoff, Rhonda Yantiss
USCAP staff reported no relevant financial relationships.